Differential Expression Analysis
EPOCH / FL14 Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
| Gene | Annotation | pval | Fold Change (log2ratio) |
|---|---|---|---|
| 2610034m16rik | RIKEN cDNA 2610034M16 gene | 1.172e-10 | 8.993e+0 |
| lilrb4 | leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 1.241e-7 | 8.580e+0 |
| gzmb | granzyme B | 1.108e-9 | 8.046e+0 |
| cst7 | cystatin F (leukocystatin) | 7.626e-8 | 7.748e+0 |
| mc2r | melanocortin 2 receptor | 5.221e-8 | 7.192e+0 |
| npy | neuropeptide Y | 1.793e-6 | 6.636e+0 |
| cd244 | CD244 natural killer cell receptor 2B4 | 1.175e-6 | 5.972e+0 |
| col5a2 | collagen, type V, alpha 2 | 1.754e-6 | 5.936e+0 |
| perp | PERP, TP53 apoptosis effector | 1.229e-7 | 5.576e+0 |
| cpa3 | carboxypeptidase A3, mast cell | 8.714e-7 | 5.566e+0 |
| mest | mesoderm specific transcript | 5.283e-8 | 5.546e+0 |
| prnp | prion protein | 3.289e-8 | 5.476e+0 |
| emilin2 | elastin microfibril interfacer 2 | 2.705e-6 | 5.350e+0 |
| ptger2 | prostaglandin E receptor 2 (subtype EP2) | 4.906e-6 | 5.274e+0 |
| st8sia6 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 | 5.608e-7 | 4.953e+0 |
| plek | pleckstrin | 1.270e-5 | 4.888e+0 |
| clec4d | C-type lectin domain family 4, member d | 1.022e-7 | 4.885e+0 |
| 9130213b05rik | RIKEN cDNA 9130213B05 gene | 4.546e-8 | 4.848e+0 |
| tmco2 | transmembrane and coiled-coil domains 2 | 8.742e-8 | 4.762e+0 |
| ottmusg00000015529 | predicted gene, OTTMUSG00000015529 | 2.883e-6 | 4.646e+0 |
| tcrg-v3 | T-cell receptor gamma, variable 3 | 2.072e-4 | 4.636e+0 |
| slc7a8 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 5.552e-7 | 4.629e+0 |
| gzmc | granzyme C | 5.966e-9 | 4.593e+0 |
| scin | scinderin | 1.180e-7 | 4.591e+0 |
| upp1 | uridine phosphorylase 1 | 1.277e-6 | 4.562e+0 |
| rnf128 | ring finger protein 128 | 1.903e-6 | 4.548e+0 |
| ccnb1ip1 | cyclin B1 interacting protein 1 | 1.526e-8 | 4.511e+0 |
| 5830405n20rik | RIKEN cDNA 5830405N20 gene | 5.664e-8 | 4.399e+0 |
| gm1964 | gene model 1964, (NCBI) | 1.306e-7 | 4.367e+0 |
| cd48 | CD48 antigen | 3.759e-7 | 4.335e+0 |
| pdgfrb | platelet derived growth factor receptor, beta polypeptide | 4.787e-8 | 4.313e+0 |
| bc023892 | cDNA sequence BC023892 | 1.927e-5 | 4.220e+0 |
| zfpm2 | zinc finger protein, multitype 2 | 1.074e-7 | 4.201e+0 |
| rims1 | regulating synaptic membrane exocytosis 1 | 2.148e-7 | 4.176e+0 |
| reep1 | receptor accessory protein 1 | 3.415e-5 | 4.174e+0 |
| rapsn | receptor-associated protein of the synapse | 2.593e-7 | 4.133e+0 |
| irs1 | insulin receptor substrate 1 | 2.421e-6 | 4.132e+0 |
| nuak1 | NUAK family, SNF1-like kinase, 1 | 4.981e-7 | 4.129e+0 |
| prss16 | protease, serine, 16 (thymus) | 4.394e-7 | 4.129e+0 |
| shisa2 | shisa homolog 2 (Xenopus laevis) | 8.951e-7 | 4.016e+0 |
| siglec5 | sialic acid binding Ig-like lectin 5 | 5.383e-6 | 3.971e+0 |
| rgs8 | regulator of G-protein signaling 8 | 1.122e-6 | 3.909e+0 |
| cntn3 | contactin 3 | 3.113e-6 | 3.905e+0 |
| tuba8 | tubulin, alpha 8 | 6.302e-6 | 3.882e+0 |
| pgm5 | phosphoglucomutase 5 | 3.380e-8 | 3.868e+0 |
| 8030474k03rik | RIKEN cDNA 8030474K03 gene | 3.554e-6 | 3.846e+0 |
| insc | inscuteable homolog (Drosophila) | 2.793e-6 | 3.846e+0 |
| mrvi1 | MRV integration site 1 | 3.687e-6 | 3.828e+0 |
| flrt3 | fibronectin leucine rich transmembrane protein 3 | 1.189e-6 | 3.778e+0 |
| bc023969 | cDNA sequence BC023969 | 2.181e-4 | 3.777e+0 |
| p2ry10 | purinergic receptor P2Y, G-protein coupled 10 | 2.964e-4 | 3.774e+0 |
| il1rl1 | interleukin 1 receptor-like 1 | 3.883e-7 | 3.760e+0 |
| treml1 | triggering receptor expressed on myeloid cells-like 1 | 1.363e-5 | 3.744e+0 |
| c77097 | expressed sequence C77097 | 9.636e-7 | 3.692e+0 |
| havcr2 | hepatitis A virus cellular receptor 2 | 1.034e-5 | 3.689e+0 |
| fcgr3 | Fc receptor, IgG, low affinity III | 2.883e-5 | 3.688e+0 |
| mapk4 | mitogen-activated protein kinase 4 | 1.050e-6 | 3.680e+0 |
| 2310076g05rik | RIKEN cDNA 2310076G05 gene | 2.807e-6 | 3.678e+0 |
| gpr174 | G protein-coupled receptor 174 | 2.782e-6 | 3.643e+0 |
| gpr65 | G-protein coupled receptor 65 | 1.258e-5 | 3.627e+0 |
| akap2 | A kinase (PRKA) anchor protein 2 | 1.558e-7 | 3.611e+0 |
| mylk3 | myosin light chain kinase 3 | 3.022e-6 | 3.600e+0 |
| dtx4 | deltex 4 homolog (Drosophila) | 9.666e-6 | 3.598e+0 |
| gpr97 | G protein-coupled receptor 97 | 7.879e-4 | 3.578e+0 |
| optn | optineurin | 1.511e-7 | 3.577e+0 |
| samd14 | sterile alpha motif domain containing 14 | 1.678e-7 | 3.483e+0 |
| ai117581 | expressed sequence AI117581 | 3.328e-5 | 3.472e+0 |
| phlda1 | pleckstrin homology-like domain, family A, member 1 | 8.541e-6 | 3.468e+0 |
| il6 | interleukin 6 | 3.715e-4 | 3.363e+0 |
| f2rl2 | coagulation factor II (thrombin) receptor-like 2 | 1.165e-5 | 3.362e+0 |
| ppp1r14c | protein phosphatase 1, regulatory (inhibitor) subunit 14c | 1.130e-8 | 3.339e+0 |
| c86595 | expressed sequence C86595 | 4.675e-5 | 3.339e+0 |
| a930003a15rik | RIKEN cDNA A930003A15 gene | 1.849e-5 | 3.330e+0 |
| cd72 | CD72 antigen | 1.829e-7 | 3.302e+0 |
| 9530019h20rik | RIKEN cDNA 9530019H20 gene | 6.506e-4 | 3.301e+0 |
| cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 2.050e-4 | 3.226e+0 |
| itga2b | integrin alpha 2b | 6.369e-6 | 3.212e+0 |
| cysltr1 | cysteinyl leukotriene receptor 1 | 6.824e-6 | 3.207e+0 |
| 4930519l02rik | RIKEN cDNA 4930519L02 gene | 1.661e-3 | 3.156e+0 |
| pde8a | phosphodiesterase 8A | 6.195e-6 | 3.154e+0 |
| hemgn | hemogen | 2.609e-8 | 3.145e+0 |
| ccr2 | chemokine (C-C motif) receptor 2 | 7.412e-6 | 3.144e+0 |
| slc24a3 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 | 1.590e-5 | 3.141e+0 |
| muc13 | mucin 13, epithelial transmembrane | 9.885e-6 | 3.121e+0 |
| il7r | interleukin 7 receptor | 1.763e-7 | 3.096e+0 |
| rbpms2 | RNA binding protein with multiple splicing 2 | 1.679e-6 | 3.096e+0 |
| 8030447m02rik | RIKEN cDNA 8030447M02 gene | 6.527e-7 | 3.077e+0 |
| idi1 | isopentenyl-diphosphate delta isomerase | 3.295e-8 | 3.071e+0 |
| egr1 | early growth response 1 | 1.430e-3 | 3.047e+0 |
| vstm2a | V-set and transmembrane domain containing 2A | 6.377e-4 | 3.036e+0 |
| serpinb2 | serine (or cysteine) peptidase inhibitor, clade B, member 2 | 2.537e-3 | 3.014e+0 |
| xlr4b | X-linked lymphocyte-regulated 4B | 7.453e-5 | 3.012e+0 |
| nlrc3 | NLR family, CARD domain containing 3 | 1.609e-5 | 2.996e+0 |
| pf4 | platelet factor 4 | 9.944e-3 | 2.987e+0 |
| gm944 | gene model 944, (NCBI) | 4.586e-7 | 2.956e+0 |
| bmp2k | BMP2 inducible kinase | 6.529e-6 | 2.954e+0 |
| csgalnact1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 3.026e-6 | 2.943e+0 |
| cd69 | CD69 antigen | 1.397e-4 | 2.939e+0 |
| actr3b | ARP3 actin-related protein 3 homolog B (yeast) | 1.728e-5 | 2.936e+0 |
| vmn2r84 | vomeronasal 2, receptor 84 | 2.518e-7 | 2.912e+0 |
| gp1ba | glycoprotein 1b, alpha polypeptide | 1.069e-2 | 2.912e+0 |
| lpl | lipoprotein lipase | 8.230e-6 | 2.904e+0 |
| f2r | coagulation factor II (thrombin) receptor | 5.720e-7 | 2.891e+0 |
| rab27b | RAB27b, member RAS oncogene family | 2.273e-7 | 2.886e+0 |
| fcer1g | Fc receptor, IgE, high affinity I, gamma polypeptide | 4.421e-5 | 2.863e+0 |
| prr16 | proline rich 16 | 2.615e-6 | 2.857e+0 |
| cth | cystathionase (cystathionine gamma-lyase) | 3.537e-5 | 2.845e+0 |
| pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 1.328e-4 | 2.832e+0 |
| dhrs3 | dehydrogenase/reductase (SDR family) member 3 | 7.669e-6 | 2.831e+0 |
| pqlc3 | PQ loop repeat containing | 1.734e-6 | 2.823e+0 |
| itgb3 | integrin beta 3 | 2.008e-5 | 2.817e+0 |
| lat | linker for activation of T cells | 1.208e-5 | 2.809e+0 |
| eya4 | eyes absent 4 homolog (Drosophila) | 4.698e-6 | 2.798e+0 |
| scd1 | stearoyl-Coenzyme A desaturase 1 | 7.739e-4 | 2.788e+0 |
| erv3 | endogenous retroviral sequence 3 | 4.966e-8 | 2.777e+0 |
| adam9 | a disintegrin and metallopeptidase domain 9 (meltrin gamma) | 2.264e-5 | 2.758e+0 |
| mylpf | myosin light chain, phosphorylatable, fast skeletal muscle | 9.692e-5 | 2.756e+0 |
| serpinb1a | serine (or cysteine) peptidase inhibitor, clade B, member 1a | 1.310e-4 | 2.753e+0 |
| arl4a | ADP-ribosylation factor-like 4A | 4.971e-7 | 2.753e+0 |
| cdk6 | cyclin-dependent kinase 6 | 1.820e-7 | 2.747e+0 |
| ncf4 | neutrophil cytosolic factor 4 | 5.442e-6 | 2.744e+0 |
| ab124611 | cDNA sequence AB124611 | 3.009e-5 | 2.712e+0 |
| gsn | gelsolin | 4.394e-9 | 2.683e+0 |
| wasf1 | WASP family 1 | 1.067e-3 | 2.681e+0 |
| trib2 | tribbles homolog 2 (Drosophila) | 2.781e-6 | 2.656e+0 |
| aw548124 | expressed sequence AW548124 | 8.420e-6 | 2.653e+0 |
| prr6 | proline-rich polypeptide 6 | 2.264e-7 | 2.649e+0 |
| arhgap6 | Rho GTPase activating protein 6 | 3.350e-7 | 2.645e+0 |
| elavl2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) | 4.305e-5 | 2.627e+0 |
| hspa4l | heat shock protein 4 like | 2.638e-7 | 2.625e+0 |
| bambi | BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) | 1.624e-4 | 2.614e+0 |
| zbtb16 | zinc finger and BTB domain containing 16 | 6.834e-6 | 2.589e+0 |
| nov | nephroblastoma overexpressed gene | 1.988e-5 | 2.589e+0 |
| spp1 | secreted phosphoprotein 1 | 4.475e-3 | 2.573e+0 |
| lss | lanosterol synthase | 5.137e-5 | 2.564e+0 |
| hmga2-ps1 | high mobility group AT-hook 2, pseudogene 1 | 1.544e-5 | 2.547e+0 |
| depdc1b | DEP domain containing 1B | 1.226e-5 | 2.539e+0 |
| sema3a | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | 3.180e-10 | 2.534e+0 |
| sgip1 | SH3-domain GRB2-like (endophilin) interacting protein 1 | 1.186e-6 | 2.532e+0 |
| gna14 | guanine nucleotide binding protein, alpha 14 | 3.745e-7 | 2.527e+0 |
| zmat3 | zinc finger matrin type 3 | 3.036e-6 | 2.527e+0 |
| cap2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 1.313e-4 | 2.512e+0 |
| h60a | histocompatibility 60a | 9.687e-7 | 2.511e+0 |
| abhd3 | abhydrolase domain containing 3 | 5.072e-8 | 2.508e+0 |
| stx11 | syntaxin 11 | 2.402e-6 | 2.507e+0 |
| trps1 | trichorhinophalangeal syndrome I (human) | 1.217e-4 | 2.502e+0 |
| slc46a3 | solute carrier family 46, member 3 | 8.022e-4 | 2.500e+0 |
| prkar2b | protein kinase, cAMP dependent regulatory, type II beta | 5.927e-7 | 2.495e+0 |
| itgal | integrin alpha L | 7.255e-8 | 2.486e+0 |
| pcdh19 | protocadherin 19 | 3.246e-6 | 2.471e+0 |
| ai447881 | expressed sequence AI447881 | 1.733e-6 | 2.469e+0 |
| 5330403d14rik | RIKEN cDNA 5330403D14 gene | 6.152e-4 | 2.462e+0 |
| gypa | glycophorin A | 7.605e-3 | 2.458e+0 |
| pmp22 | peripheral myelin protein 22 | 4.771e-4 | 2.454e+0 |
| tm7sf2 | transmembrane 7 superfamily member 2 | 2.244e-5 | 2.453e+0 |
| acsl4 | acyl-CoA synthetase long-chain family member 4 | 3.697e-6 | 2.450e+0 |
| dbc1 | deleted in bladder cancer 1 (human) | 1.613e-6 | 2.446e+0 |
| slamf1 | signaling lymphocytic activation molecule family member 1 | 3.049e-5 | 2.446e+0 |
| tshz1 | teashirt zinc finger family member 1 | 5.283e-5 | 2.444e+0 |
| slc39a4 | solute carrier family 39 (zinc transporter), member 4 | 2.955e-5 | 2.444e+0 |
| obscn | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 7.228e-4 | 2.442e+0 |
| fbp1 | fructose bisphosphatase 1 | 2.856e-4 | 2.430e+0 |
| loc100040592 | similar to Hmgcs1 protein | 6.419e-5 | 2.424e+0 |
| serpine2 | serine (or cysteine) peptidase inhibitor, clade E, member 2 | 8.195e-3 | 2.417e+0 |
| gpc3 | glypican 3 | 9.891e-6 | 2.409e+0 |
| pik3cb | phosphatidylinositol 3-kinase, catalytic, beta polypeptide | 2.610e-4 | 2.395e+0 |
| nupr1 | nuclear protein 1 | 1.795e-3 | 2.395e+0 |
| kynu | kynureninase (L-kynurenine hydrolase) | 3.274e-4 | 2.394e+0 |
| mcts2 | malignant T cell amplified sequence 2 | 4.833e-4 | 2.392e+0 |
| inpp4b | inositol polyphosphate-4-phosphatase, type II | 1.256e-5 | 2.383e+0 |
| darc | Duffy blood group, chemokine receptor | 5.185e-5 | 2.379e+0 |
| endod1 | endonuclease domain containing 1 | 3.122e-7 | 2.374e+0 |
| mt1 | metallothionein 1 | 2.619e-5 | 2.370e+0 |
| 2610029i01rik | RIKEN cDNA 2610029I01 gene | 1.311e-6 | 2.361e+0 |
| lgals9 | lectin, galactose binding, soluble 9 | 9.516e-6 | 2.355e+0 |
| asxl3 | additional sex combs like 3 (Drosophila) | 1.089e-5 | 2.350e+0 |
| esco2 | establishment of cohesion 1 homolog 2 (S. cerevisiae) | 4.223e-5 | 2.347e+0 |
| a530088e08rik | RIKEN cDNA A530088E08 gene | 2.344e-5 | 2.345e+0 |
| gpr34 | G protein-coupled receptor 34 | 5.185e-8 | 2.330e+0 |
| limch1 | LIM and calponin homology domains 1 | 1.612e-8 | 2.328e+0 |
| itm2c | integral membrane protein 2C | 2.296e-5 | 2.323e+0 |
| f13a1 | coagulation factor XIII, A1 subunit | 3.922e-5 | 2.323e+0 |
| bcmo1 | beta-carotene 15,15'-monooxygenase | 1.275e-6 | 2.315e+0 |
| prtg | protogenin homolog (Gallus gallus) | 9.010e-8 | 2.313e+0 |
| wwtr1 | WW domain containing transcription regulator 1 | 1.860e-5 | 2.310e+0 |
| ngly1 | N-glycanase 1 | 2.776e-6 | 2.307e+0 |
| pitrm1 | pitrilysin metallepetidase 1 | 5.216e-7 | 2.303e+0 |
| loc100045709 | similar to ubiquitin-like domain containing CTD phosphatase 1 | 4.206e-4 | 2.302e+0 |
| gclm | glutamate-cysteine ligase , modifier subunit | 4.139e-3 | 2.289e+0 |
| bcat2 | branched chain aminotransferase 2, mitochondrial | 1.049e-5 | 2.286e+0 |
| ank | progressive ankylosis | 4.781e-4 | 2.278e+0 |
| ero1l | ERO1-like (S. cerevisiae) | 1.534e-4 | 2.276e+0 |
| tcrb-v8.2 | T-cell receptor beta, variable 8.2 | 5.506e-4 | 2.269e+0 |
| rnf180 | ring finger protein 180 | 1.650e-5 | 2.262e+0 |
| 2310050p20rik | RIKEN cDNA 2310050P20 gene | 1.631e-5 | 2.258e+0 |
| mvd | mevalonate (diphospho) decarboxylase | 4.357e-8 | 2.250e+0 |
| golm1 | golgi membrane protein 1 | 8.914e-4 | 2.238e+0 |
| asns | asparagine synthetase | 1.993e-5 | 2.232e+0 |
| tmem87a | transmembrane protein 87A | 1.854e-5 | 2.230e+0 |
| clec1b | C-type lectin domain family 1, member b | 2.221e-2 | 2.223e+0 |
| rspry1 | ring finger and SPRY domain containing 1 | 7.378e-5 | 2.222e+0 |
| rasl11a | RAS-like, family 11, member A | 1.163e-2 | 2.218e+0 |
| sqle | squalene epoxidase | 1.531e-5 | 2.216e+0 |
| ptgds2 | prostaglandin D2 synthase 2, hematopoietic | 6.036e-4 | 2.215e+0 |
| plscr1 | phospholipid scramblase 1 | 3.579e-5 | 2.200e+0 |
| plod2 | procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 | 2.591e-5 | 2.200e+0 |
| gnai1 | guanine nucleotide binding protein (G protein), alpha inhibiting 1 | 3.045e-6 | 2.200e+0 |
| clic6 | chloride intracellular channel 6 | 1.293e-5 | 2.188e+0 |
| 4930486l24rik | RIKEN cDNA 4930486L24 gene | 3.198e-4 | 2.185e+0 |
| ehd3 | EH-domain containing 3 | 1.048e-4 | 2.184e+0 |
| 1700026l06rik | RIKEN cDNA 1700026L06 gene | 1.273e-4 | 2.181e+0 |
| stxbp6 | syntaxin binding protein 6 (amisyn) | 7.800e-7 | 2.174e+0 |
| thbs1 | thrombospondin 1 | 2.229e-2 | 2.168e+0 |
| lrrn3 | leucine rich repeat protein 3, neuronal | 2.997e-3 | 2.156e+0 |
| ptger3 | prostaglandin E receptor 3 (subtype EP3) | 6.117e-5 | 2.151e+0 |
| c030044c12rik | RIKEN cDNA C030044C12 gene | 1.467e-3 | 2.151e+0 |
| pnoc | prepronociceptin | 4.021e-6 | 2.151e+0 |
| ai844685 | expressed sequence AI844685 | 2.863e-5 | 2.150e+0 |
| gstt3 | glutathione S-transferase, theta 3 | 7.146e-5 | 2.141e+0 |
| dnajc6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | 8.048e-8 | 2.140e+0 |
| nckap1 | NCK-associated protein 1 | 4.134e-4 | 2.137e+0 |
| dcpp3 | demilune cell and parotid protein 3 | 8.934e-6 | 2.136e+0 |
| klhl25 | kelch-like 25 (Drosophila) | 6.345e-6 | 2.136e+0 |
| col1a2 | collagen, type I, alpha 2 | 1.954e-7 | 2.120e+0 |
| plk1 | polo-like kinase 1 (Drosophila) | 9.915e-7 | 2.107e+0 |
| tcrg-v4 | T-cell receptor gamma, variable 4 | 8.183e-4 | 2.106e+0 |
| csf2rb | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 1.555e-4 | 2.105e+0 |
| ccrn4l | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 5.218e-5 | 2.104e+0 |
| pros1 | protein S (alpha) | 4.103e-5 | 2.104e+0 |
| socs2 | suppressor of cytokine signaling 2 | 1.585e-5 | 2.101e+0 |
| csf2rb2 | colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) | 8.434e-3 | 2.100e+0 |
| 5430407p10rik | RIKEN cDNA 5430407P10 gene | 4.695e-5 | 2.098e+0 |
| gan | giant axonal neuropathy | 4.551e-3 | 2.089e+0 |
| cap1 | CAP, adenylate cyclase-associated protein 1 (yeast) | 2.662e-6 | 2.088e+0 |
| slco3a1 | solute carrier organic anion transporter family, member 3a1 | 2.766e-6 | 2.087e+0 |
| myo6 | myosin VI | 1.712e-7 | 2.085e+0 |
| creb3l1 | cAMP responsive element binding protein 3-like 1 | 4.090e-4 | 2.081e+0 |
| ai956758 | expressed sequence AI956758 | 2.686e-6 | 2.075e+0 |
| exoc6b | exocyst complex component 6B | 4.825e-5 | 2.075e+0 |
| glyat | glycine-N-acyltransferase | 1.966e-7 | 2.074e+0 |
| renbp | renin binding protein | 9.334e-5 | 2.073e+0 |
| clec4e | C-type lectin domain family 4, member e | 7.097e-5 | 2.066e+0 |
| tmem9b | TMEM9 domain family, member B | 9.206e-6 | 2.065e+0 |
| slpi | secretory leukocyte peptidase inhibitor | 1.584e-4 | 2.058e+0 |
| adamtsl1 | ADAMTS-like 1 | 1.091e-7 | 2.046e+0 |
| abca4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 3.017e-5 | 2.045e+0 |
| h2-oa | histocompatibility 2, O region alpha locus | 1.152e-4 | 2.043e+0 |
| ottmusg00000011070 | predicted gene, OTTMUSG00000011070 | 1.172e-4 | 2.040e+0 |
| 2610528j11rik | RIKEN cDNA 2610528J11 gene | 5.110e-4 | 2.040e+0 |
| asf1b | ASF1 anti-silencing function 1 homolog B (S. cerevisiae) | 2.252e-4 | 2.039e+0 |
| hacl1 | 2-hydroxyacyl-CoA lyase 1 | 8.933e-6 | 2.031e+0 |
| loc677224 | similar to RIKEN cDNA 2810457I06 | 5.255e-6 | 2.030e+0 |
| csrp1 | cysteine and glycine-rich protein 1 | 3.161e-6 | 2.025e+0 |
| slc22a23 | solute carrier family 22, member 23 | 7.476e-7 | 2.023e+0 |
| d11ertd717e | DNA segment, Chr 11, ERATO Doi 717, expressed | 1.636e-4 | 2.021e+0 |
| dmd | dystrophin, muscular dystrophy | 6.398e-6 | 2.013e+0 |
| loc621549 | hypothetical protein LOC621549 | 3.624e-5 | 2.011e+0 |
| gchfr | GTP cyclohydrolase I feedback regulator | 6.780e-5 | 2.011e+0 |
| 9230114k14rik | RIKEN cDNA 9230114K14 gene | 5.939e-6 | 2.004e+0 |
| sc4mol | sterol-C4-methyl oxidase-like | 1.628e-6 | 2.003e+0 |
| ncf2 | neutrophil cytosolic factor 2 | 1.482e-4 | -2.010e+0 |
| loc100047856 | similar to calponin 3, acidic | 1.561e-5 | -2.012e+0 |
| il18 | interleukin 18 | 4.832e-4 | -2.016e+0 |
| c76336 | expressed sequence C76336 | 7.624e-4 | -2.018e+0 |
| 2610019n06rik | RIKEN cDNA 2610019N06 gene | 1.541e-6 | -2.026e+0 |
| d130051d11rik | RIKEN cDNA D130051D11 gene | 3.722e-3 | -2.028e+0 |
| spata5l1 | spermatogenesis associated 5-like 1 | 1.135e-2 | -2.029e+0 |
| lbp | lipopolysaccharide binding protein | 6.367e-6 | -2.030e+0 |
| npepl1 | aminopeptidase-like 1 | 4.197e-5 | -2.034e+0 |
| nhedc2 | Na+/H+ exchanger domain containing 2 | 1.766e-4 | -2.035e+0 |
| ubtd2 | ubiquitin domain containing 2 | 6.908e-3 | -2.040e+0 |
| 2010315b03rik | RIKEN cDNA 2010315B03 gene | 6.474e-6 | -2.043e+0 |
| afap1l1 | actin filament associated protein 1-like 1 | 6.457e-6 | -2.049e+0 |
| trim12 | tripartite motif-containing 12 | 9.094e-7 | -2.052e+0 |
| cbr1 | carbonyl reductase 1 | 1.904e-5 | -2.054e+0 |
| loc100048050 | similar to calcium-independent alpha-latrotoxin receptor homolog 2 | 2.658e-7 | -2.056e+0 |
| tpm2 | tropomyosin 2, beta | 6.290e-5 | -2.057e+0 |
| 9030411k21rik | RIKEN cDNA 9030411K21 gene | 6.964e-5 | -2.059e+0 |
| asprv1 | aspartic peptidase, retroviral-like 1 | 1.485e-5 | -2.060e+0 |
| il21r | interleukin 21 receptor | 5.083e-6 | -2.060e+0 |
| lzts2 | leucine zipper, putative tumor suppressor 2 | 9.069e-5 | -2.061e+0 |
| ottmusg00000011065 | predicted gene, OTTMUSG00000011065 | 7.388e-5 | -2.061e+0 |
| myh10 | myosin, heavy polypeptide 10, non-muscle | 4.537e-5 | -2.062e+0 |
| pde6h | phosphodiesterase 6H, cGMP-specific, cone, gamma | 5.316e-6 | -2.064e+0 |
| cd86 | CD86 antigen | 2.535e-6 | -2.064e+0 |
| dock9 | dedicator of cytokinesis 9 | 3.501e-5 | -2.065e+0 |
| bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 5.224e-5 | -2.065e+0 |
| rhag | Rhesus blood group-associated A glycoprotein | 1.481e-2 | -2.069e+0 |
| dab2ip | disabled homolog 2 (Drosophila) interacting protein | 1.109e-4 | -2.070e+0 |
| apoc1 | apolipoprotein C-I | 4.114e-4 | -2.071e+0 |
| d930017j03rik | RIKEN cDNA D930017J03 gene | 8.427e-5 | -2.082e+0 |
| rab39 | RAB39, member RAS oncogene family | 7.979e-4 | -2.083e+0 |
| satb1 | special AT-rich sequence binding protein 1 | 5.294e-4 | -2.084e+0 |
| cttn | cortactin | 2.952e-6 | -2.086e+0 |
| s1pr1 | sphingosine-1-phosphate receptor 1 | 1.206e-4 | -2.088e+0 |
| ckap4 | cytoskeleton-associated protein 4 | 7.052e-8 | -2.090e+0 |
| pcp4l1 | Purkinje cell protein 4-like 1 | 7.718e-6 | -2.094e+0 |
| bc005512 | cDNA sequence BC005512 | 5.137e-5 | -2.098e+0 |
| pdgfb | platelet derived growth factor, B polypeptide | 5.638e-7 | -2.100e+0 |
| p2ry14 | purinergic receptor P2Y, G-protein coupled, 14 | 1.767e-3 | -2.100e+0 |
| eps8 | epidermal growth factor receptor pathway substrate 8 | 2.374e-5 | -2.101e+0 |
| loc100046855 | similar to BKLF | 1.242e-7 | -2.105e+0 |
| rabl2a | RAB, member of RAS oncogene family-like 2A | 8.808e-5 | -2.111e+0 |
| igsf6 | immunoglobulin superfamily, member 6 | 1.147e-4 | -2.111e+0 |
| gpr124 | G protein-coupled receptor 124 | 8.651e-6 | -2.117e+0 |
| fscn1 | fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) | 1.848e-8 | -2.124e+0 |
| ppp1r3b | protein phosphatase 1, regulatory (inhibitor) subunit 3B | 1.384e-4 | -2.125e+0 |
| p2ry13 | purinergic receptor P2Y, G-protein coupled 13 | 1.309e-4 | -2.126e+0 |
| heg1 | HEG homolog 1 (zebrafish) | 3.337e-4 | -2.127e+0 |
| d930050a07rik | RIKEN cDNA D930050A07 gene | 1.403e-4 | -2.128e+0 |
| mdk | midkine | 1.978e-4 | -2.129e+0 |
| parp3 | poly (ADP-ribose) polymerase family, member 3 | 2.623e-6 | -2.133e+0 |
| nat1 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | 5.913e-4 | -2.133e+0 |
| acy3 | aspartoacylase (aminoacylase) 3 | 5.110e-4 | -2.135e+0 |
| acpl2 | acid phosphatase-like 2 | 2.426e-5 | -2.137e+0 |
| tmem37 | transmembrane protein 37 | 1.311e-5 | -2.138e+0 |
| tmem204 | transmembrane protein 204 | 9.246e-6 | -2.143e+0 |
| pir | pirin | 4.259e-4 | -2.143e+0 |
| bc067047 | cDNA sequence BC067047 | 6.390e-5 | -2.147e+0 |
| 2210016f16rik | RIKEN cDNA 2210016F16 gene | 1.763e-4 | -2.148e+0 |
| hoxb3 | homeo box B3 | 1.889e-7 | -2.148e+0 |
| rnf125 | ring finger protein 125 | 3.341e-5 | -2.150e+0 |
| tspan8 | tetraspanin 8 | 1.978e-6 | -2.153e+0 |
| tmtc2 | transmembrane and tetratricopeptide repeat containing 2 | 5.631e-5 | -2.158e+0 |
| dhdh | dihydrodiol dehydrogenase (dimeric) | 1.294e-4 | -2.160e+0 |
| vnn1 | vanin 1 | 2.689e-3 | -2.163e+0 |
| phactr2 | phosphatase and actin regulator 2 | 4.941e-8 | -2.167e+0 |
| wtip | WT1-interacting protein | 2.287e-5 | -2.167e+0 |
| sgk1 | serum/glucocorticoid regulated kinase 1 | 1.203e-5 | -2.168e+0 |
| smad6 | MAD homolog 6 (Drosophila) | 6.063e-4 | -2.175e+0 |
| tgif1 | TGFB-induced factor homeobox 1 | 2.804e-4 | -2.181e+0 |
| hopx | HOP homeobox | 7.048e-4 | -2.184e+0 |
| snx24 | sorting nexing 24 | 1.409e-4 | -2.188e+0 |
| mboat2 | membrane bound O-acyltransferase domain containing 2 | 6.766e-6 | -2.196e+0 |
| thbd | thrombomodulin | 1.921e-5 | -2.201e+0 |
| zcchc3 | zinc finger, CCHC domain containing 3 | 2.019e-5 | -2.208e+0 |
| 9030611o19rik | RIKEN cDNA 9030611O19 gene | 6.911e-6 | -2.211e+0 |
| mcoln2 | mucolipin 2 | 1.268e-4 | -2.211e+0 |
| zfp709 | zinc finger protein 709 | 1.757e-4 | -2.221e+0 |
| mdfic | MyoD family inhibitor domain containing | 8.341e-5 | -2.222e+0 |
| vwf | Von Willebrand factor homolog | 8.542e-4 | -2.229e+0 |
| ptplad2 | protein tyrosine phosphatase-like A domain containing 2 | 1.231e-6 | -2.231e+0 |
| cldn7 | claudin 7 | 4.275e-6 | -2.232e+0 |
| 1110018j18rik | RIKEN cDNA 1110018J18 gene | 2.779e-6 | -2.238e+0 |
| hspa12b | heat shock protein 12B | 8.415e-5 | -2.242e+0 |
| reck | reversion-inducing-cysteine-rich protein with kazal motifs | 3.362e-6 | -2.254e+0 |
| cyp39a1 | cytochrome P450, family 39, subfamily a, polypeptide 1 | 1.795e-5 | -2.256e+0 |
| phlda2 | pleckstrin homology-like domain, family A, member 2 | 1.499e-4 | -2.257e+0 |
| casp12 | caspase 12 | 3.241e-6 | -2.259e+0 |
| aph1c | anterior pharynx defective 1c homolog (C. elegans) | 4.928e-7 | -2.262e+0 |
| afp | alpha fetoprotein | 2.149e-4 | -2.263e+0 |
| 2010004m13rik | RIKEN cDNA 2010004M13 gene | 1.959e-7 | -2.264e+0 |
| ptprc | protein tyrosine phosphatase, receptor type, C | 2.906e-4 | -2.265e+0 |
| d12ertd553e | DNA segment, Chr 12, ERATO Doi 553, expressed | 4.986e-5 | -2.265e+0 |
| trip6 | thyroid hormone receptor interactor 6 | 3.871e-5 | -2.266e+0 |
| cfp | complement factor properdin | 4.608e-5 | -2.269e+0 |
| ecm1 | extracellular matrix protein 1 | 9.604e-6 | -2.278e+0 |
| 6720422m22rik | RIKEN cDNA 6720422M22 gene | 2.189e-5 | -2.281e+0 |
| 5930433n17rik | RIKEN cDNA 5930433N17 gene | 1.141e-3 | -2.288e+0 |
| dkkl1 | dickkopf-like 1 | 2.089e-5 | -2.290e+0 |
| tmem154 | transmembrane protein 154 | 5.346e-5 | -2.291e+0 |
| cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 5.633e-6 | -2.292e+0 |
| rec8 | REC8 homolog (yeast) | 6.319e-5 | -2.298e+0 |
| chrnb1 | cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) | 7.148e-5 | -2.305e+0 |
| s100a11 | S100 calcium binding protein A11 (calgizzarin) | 3.377e-6 | -2.317e+0 |
| 2310057j16rik | RIKEN cDNA 2310057J16 gene | 3.458e-4 | -2.321e+0 |
| gsdmd | gasdermin D | 1.507e-5 | -2.333e+0 |
| st8sia4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 9.731e-6 | -2.335e+0 |
| cc2d2a | coiled-coil and C2 domain containing 2A | 1.226e-5 | -2.336e+0 |
| cd302 | CD302 antigen | 2.702e-6 | -2.366e+0 |
| ndrg2 | N-myc downstream regulated gene 2 | 2.435e-5 | -2.373e+0 |
| capsl | calcyphosine-like | 8.420e-5 | -2.374e+0 |
| 5230400m03rik | RIKEN cDNA 5230400M03 gene | 1.482e-6 | -2.386e+0 |
| slc35d3 | solute carrier family 35, member D3 | 1.172e-2 | -2.389e+0 |
| 4933433k01rik | RIKEN cDNA 4933433K01 gene | 7.057e-4 | -2.391e+0 |
| rnf122 | ring finger protein 122 | 5.312e-4 | -2.406e+0 |
| ifitm3 | interferon induced transmembrane protein 3 | 1.488e-4 | -2.408e+0 |
| sept4 | septin 4 | 1.948e-5 | -2.413e+0 |
| gbp3 | guanylate binding protein 3 | 1.391e-6 | -2.419e+0 |
| sdc1 | syndecan 1 | 1.137e-6 | -2.425e+0 |
| d930028f11rik | RIKEN cDNA D930028F11 gene | 3.000e-3 | -2.426e+0 |
| rpl39l | ribosomal protein L39-like | 2.800e-3 | -2.434e+0 |
| cyp7b1 | cytochrome P450, family 7, subfamily b, polypeptide 1 | 1.499e-6 | -2.444e+0 |
| ldhb | lactate dehydrogenase B | 1.230e-5 | -2.458e+0 |
| a130071d04rik | RIKEN cDNA A130071D04 gene | 1.713e-3 | -2.458e+0 |
| hoxa10 | homeo box A10 | 2.379e-8 | -2.460e+0 |
| tmem17 | transmembrane protein 17 | 1.596e-4 | -2.463e+0 |
| loc100044979 | similar to Gpr137b protein | 1.531e-5 | -2.463e+0 |
| kank2 | KN motif and ankyrin repeat domains 2 | 1.286e-7 | -2.468e+0 |
| serinc3 | serine incorporator 3 | 4.466e-8 | -2.469e+0 |
| 4833403j16rik | RIKEN cDNA 4833403J16 gene | 2.154e-6 | -2.474e+0 |
| il4 | interleukin 4 | 1.520e-5 | -2.477e+0 |
| sesn1 | sestrin 1 | 1.350e-6 | -2.478e+0 |
| 4932413o14rik | RIKEN cDNA 4932413O14 gene | 2.786e-4 | -2.479e+0 |
| zfp467 | zinc finger protein 467 | 1.201e-5 | -2.480e+0 |
| gm2a | GM2 ganglioside activator protein | 1.353e-6 | -2.480e+0 |
| 6720489n17rik | RIKEN cDNA 6720489N17 gene | 2.246e-5 | -2.491e+0 |
| ttpa | tocopherol (alpha) transfer protein | 3.058e-4 | -2.492e+0 |
| slc16a9 | solute carrier family 16 (monocarboxylic acid transporters), member 9 | 5.129e-5 | -2.494e+0 |
| leprel2 | leprecan-like 2 | 7.131e-5 | -2.498e+0 |
| crispld1 | cysteine-rich secretory protein LCCL domain containing 1 | 1.632e-4 | -2.506e+0 |
| rasgrp3 | RAS, guanyl releasing protein 3 | 3.301e-5 | -2.506e+0 |
| dusp6 | dual specificity phosphatase 6 | 5.304e-4 | -2.507e+0 |
| acp5 | acid phosphatase 5, tartrate resistant | 7.926e-5 | -2.508e+0 |
| naprt1 | nicotinate phosphoribosyltransferase domain containing 1 | 3.863e-5 | -2.513e+0 |
| sept10 | septin 10 | 6.362e-6 | -2.515e+0 |
| igf2 | insulin-like growth factor 2 | 3.147e-4 | -2.519e+0 |
| plagl1 | pleiomorphic adenoma gene-like 1 | 1.514e-4 | -2.519e+0 |
| csf3r | colony stimulating factor 3 receptor (granulocyte) | 9.847e-5 | -2.522e+0 |
| otos | otospiralin | 5.424e-4 | -2.527e+0 |
| mpzl1 | myelin protein zero-like 1 | 6.822e-7 | -2.529e+0 |
| bc013712 | cDNA sequence BC013712 | 2.678e-4 | -2.532e+0 |
| ccl4 | chemokine (C-C motif) ligand 4 | 6.254e-5 | -2.537e+0 |
| adrb2 | adrenergic receptor, beta 2 | 3.639e-4 | -2.539e+0 |
| ptprcap | protein tyrosine phosphatase, receptor type, C polypeptide-associated protein | 1.180e-6 | -2.542e+0 |
| 8030497i03rik | RIKEN cDNA 8030497I03 gene | 4.616e-4 | -2.542e+0 |
| cav2 | caveolin 2 | 1.518e-5 | -2.543e+0 |
| hist1h2bc | histone cluster 1, H2bc | 4.155e-7 | -2.544e+0 |
| psma8 | proteasome (prosome, macropain) subunit, alpha type, 8 | 1.402e-3 | -2.564e+0 |
| 5830416p10rik | RIKEN cDNA 5830416P10 gene | 1.015e-4 | -2.572e+0 |
| rian | RNA imprinted and accumulated in nucleus | 3.221e-5 | -2.578e+0 |
| tead2 | TEA domain family member 2 | 2.245e-5 | -2.580e+0 |
| myo7a | myosin VIIa | 3.573e-5 | -2.585e+0 |
| guca1a | guanylate cyclase activator 1a (retina) | 2.371e-6 | -2.592e+0 |
| 2610305j24rik | RIKEN cDNA 2610305J24 gene | 2.798e-4 | -2.592e+0 |
| flt3 | FMS-like tyrosine kinase 3 | 2.648e-6 | -2.594e+0 |
| b3galnt1 | UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 | 1.061e-5 | -2.598e+0 |
| kctd12b | potassium channel tetramerisation domain containing 12b | 1.107e-7 | -2.604e+0 |
| rbp1 | retinol binding protein 1, cellular | 6.564e-10 | -2.608e+0 |
| b3galtl | beta 1,3-galactosyltransferase-like | 1.826e-7 | -2.613e+0 |
| eraf | erythroid associated factor | 5.280e-3 | -2.613e+0 |
| slc35d2 | solute carrier family 35, member D2 | 7.930e-5 | -2.622e+0 |
| sh3gl3 | SH3-domain GRB2-like 3 | 8.302e-6 | -2.627e+0 |
| gimap5 | GTPase, IMAP family member 5 | 5.016e-6 | -2.631e+0 |
| stap1 | signal transducing adaptor family member 1 | 1.400e-6 | -2.631e+0 |
| slc18a2 | solute carrier family 18 (vesicular monoamine), member 2 | 6.532e-5 | -2.636e+0 |
| loc552908 | hypothetical LOC552908 | 5.198e-3 | -2.637e+0 |
| pkig | protein kinase inhibitor, gamma | 1.081e-6 | -2.639e+0 |
| prdm16 | PR domain containing 16 | 1.178e-6 | -2.642e+0 |
| casp1 | caspase 1 | 7.367e-6 | -2.644e+0 |
| icam1 | intercellular adhesion molecule 1 | 3.271e-5 | -2.658e+0 |
| rassf5 | Ras association (RalGDS/AF-6) domain family member 5 | 1.269e-5 | -2.667e+0 |
| tbxas1 | thromboxane A synthase 1, platelet | 5.280e-7 | -2.667e+0 |
| loc100039864 | hypothetical protein LOC100039864 | 1.111e-5 | -2.673e+0 |
| klhl13 | kelch-like 13 (Drosophila) | 1.502e-5 | -2.679e+0 |
| matk | megakaryocyte-associated tyrosine kinase | 4.953e-7 | -2.680e+0 |
| serpinh1 | serine (or cysteine) peptidase inhibitor, clade H, member 1 | 4.575e-6 | -2.690e+0 |
| cd99 | CD99 antigen | 9.276e-5 | -2.690e+0 |
| six6os1 | Six6 opposite strand transcript 1 | 9.791e-7 | -2.694e+0 |
| gimap1 | GTPase, IMAP family member 1 | 6.778e-6 | -2.701e+0 |
| trf | transferrin | 1.790e-6 | -2.702e+0 |
| gdf3 | growth differentiation factor 3 | 4.717e-7 | -2.716e+0 |
| d430019h16rik | RIKEN cDNA D430019H16 gene | 1.378e-5 | -2.720e+0 |
| chd3 | chromodomain helicase DNA binding protein 3 | 7.154e-6 | -2.733e+0 |
| 2900006b11rik | RIKEN cDNA 2900006B11 gene | 1.763e-6 | -2.736e+0 |
| tnfsf10 | tumor necrosis factor (ligand) superfamily, member 10 | 8.642e-7 | -2.736e+0 |
| ldb2 | LIM domain binding 2 | 1.983e-7 | -2.748e+0 |
| tnfrsf25 | tumor necrosis factor receptor superfamily, member 25 | 7.358e-5 | -2.754e+0 |
| 2310034g01rik | RIKEN cDNA 2310034G01 gene | 6.082e-5 | -2.767e+0 |
| igf1 | insulin-like growth factor 1 | 2.293e-5 | -2.767e+0 |
| 1700097n02rik | RIKEN cDNA 1700097N02 gene | 2.143e-5 | -2.775e+0 |
| capg | capping protein (actin filament), gelsolin-like | 3.133e-7 | -2.782e+0 |
| msrb3 | methionine sulfoxide reductase B3 | 2.096e-4 | -2.786e+0 |
| scarf1 | scavenger receptor class F, member 1 | 3.548e-7 | -2.788e+0 |
| tsix | X (inactive)-specific transcript, antisense | 2.050e-8 | -2.796e+0 |
| rasip1 | Ras interacting protein 1 | 1.429e-5 | -2.800e+0 |
| 3110007f17rik | RIKEN cDNA 3110007F17 gene | 5.811e-5 | -2.803e+0 |
| tgm2 | transglutaminase 2, C polypeptide | 8.119e-6 | -2.811e+0 |
| loc625360 | similar to 2-cell-stage, variable group, member 3 | 1.002e-4 | -2.815e+0 |
| ccl27 | chemokine (C-C motif) ligand 27 | 2.247e-5 | -2.817e+0 |
| rcn3 | reticulocalbin 3, EF-hand calcium binding domain | 3.616e-7 | -2.818e+0 |
| rab11fip5 | RAB11 family interacting protein 5 (class I) | 7.398e-6 | -2.820e+0 |
| vill | villin-like | 1.148e-5 | -2.834e+0 |
| aqp1 | aquaporin 1 | 3.640e-6 | -2.834e+0 |
| epsti1 | epithelial stromal interaction 1 (breast) | 1.150e-6 | -2.835e+0 |
| acyp2 | acylphosphatase 2, muscle type | 5.662e-4 | -2.871e+0 |
| 1700012d01rik | RIKEN cDNA 1700012D01 gene | 1.129e-5 | -2.880e+0 |
| dleu7 | deleted in lymphocytic leukemia, 7 | 1.148e-4 | -2.885e+0 |
| hoxa5 | homeo box A5 | 8.764e-7 | -2.895e+0 |
| igf2bp1 | insulin-like growth factor 2 mRNA binding protein 1 | 3.522e-7 | -2.896e+0 |
| c730049o14rik | RIKEN cDNA C730049O14 gene | 1.472e-6 | -2.896e+0 |
| tyrobp | TYRO protein tyrosine kinase binding protein | 1.006e-5 | -2.902e+0 |
| gprasp2 | G protein-coupled receptor associated sorting protein 2 | 2.593e-5 | -2.905e+0 |
| gja1 | gap junction protein, alpha 1 | 1.098e-4 | -2.908e+0 |
| hist3h2ba | histone cluster 3, H2ba | 1.152e-5 | -2.910e+0 |
| d730035f11rik | RIKEN cDNA D730035F11 gene | 5.915e-7 | -2.917e+0 |
| 2810055g20rik | RIKEN cDNA 2810055G20 gene | 4.244e-6 | -2.918e+0 |
| marcks | myristoylated alanine rich protein kinase C substrate | 8.206e-10 | -2.933e+0 |
| abcg3 | ATP-binding cassette, sub-family G (WHITE), member 3 | 7.903e-7 | -2.934e+0 |
| tmem71 | transmembrane protein 71 | 9.718e-5 | -2.946e+0 |
| rps4y2 | ribosomal protein S4, Y-linked 2 | 1.685e-4 | -2.947e+0 |
| dusp22 | dual specificity phosphatase 22 | 3.735e-5 | -2.953e+0 |
| cyp4b1 | cytochrome P450, family 4, subfamily b, polypeptide 1 | 3.439e-6 | -2.953e+0 |
| ai747699 | expressed sequence AI747699 | 3.224e-8 | -2.963e+0 |
| tmem98 | transmembrane protein 98 | 2.026e-7 | -2.972e+0 |
| pygl | liver glycogen phosphorylase | 4.103e-8 | -3.001e+0 |
| iigp1 | interferon inducible GTPase 1 | 2.637e-5 | -3.003e+0 |
| slfn8 | schlafen 8 | 2.546e-5 | -3.022e+0 |
| ly6a | lymphocyte antigen 6 complex, locus A | 8.781e-4 | -3.039e+0 |
| sgk3 | serum/glucocorticoid regulated kinase 3 | 1.642e-7 | -3.046e+0 |
| tnfrsf18 | tumor necrosis factor receptor superfamily, member 18 | 1.222e-5 | -3.047e+0 |
| hprt1 | hypoxanthine guanine phosphoribosyl transferase 1 | 3.023e-8 | -3.055e+0 |
| cyp2j9 | cytochrome P450, family 2, subfamily j, polypeptide 9 | 3.262e-6 | -3.089e+0 |
| hsh2d | hematopoietic SH2 domain containing | 4.867e-5 | -3.098e+0 |
| e230032d23rik | RIKEN cDNA E230032D23 gene | 1.756e-5 | -3.100e+0 |
| 100043775 | predicted gene, 100043775 | 1.551e-6 | -3.110e+0 |
| flywch2 | FLYWCH family member 2 | 3.786e-5 | -3.117e+0 |
| capn2 | calpain 2 | 4.777e-5 | -3.119e+0 |
| mllt3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | 1.262e-5 | -3.120e+0 |
| 2400009b08rik | RIKEN cDNA 2400009B08 gene | 6.051e-6 | -3.135e+0 |
| zfp429 | zinc finger protein 429 | 1.749e-5 | -3.144e+0 |
| camk1 | calcium/calmodulin-dependent protein kinase I | 4.114e-8 | -3.145e+0 |
| hoxb5 | homeo box B5 | 2.158e-6 | -3.146e+0 |
| serpinf1 | serine (or cysteine) peptidase inhibitor, clade F, member 1 | 2.631e-8 | -3.147e+0 |
| cox6b2 | cytochrome c oxidase subunit VIb polypeptide 2 | 1.869e-8 | -3.150e+0 |
| 2610528g24rik | RIKEN cDNA 2610528G24 gene | 2.037e-5 | -3.155e+0 |
| pglyrp1 | peptidoglycan recognition protein 1 | 1.059e-6 | -3.184e+0 |
| trim47 | tripartite motif-containing 47 | 1.630e-5 | -3.196e+0 |
| pcbd1 | pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1 | 2.048e-6 | -3.198e+0 |
| b4galt6 | UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 | 1.550e-8 | -3.198e+0 |
| dlk1 | delta-like 1 homolog (Drosophila) | 2.315e-8 | -3.199e+0 |
| hist1h4i | histone cluster 1, H4i | 2.646e-6 | -3.201e+0 |
| 1700040l02rik | RIKEN cDNA 1700040L02 gene | 1.164e-5 | -3.214e+0 |
| cd24a | CD24a antigen | 6.184e-8 | -3.232e+0 |
| efna1 | ephrin A1 | 2.945e-5 | -3.247e+0 |
| ccnd1 | cyclin D1 | 7.118e-9 | -3.249e+0 |
| tceal1 | transcription elongation factor A (SII)-like 1 | 4.858e-7 | -3.249e+0 |
| adrbk2 | adrenergic receptor kinase, beta 2 | 1.619e-6 | -3.253e+0 |
| gfi1 | growth factor independent 1 | 8.953e-6 | -3.260e+0 |
| ifi44 | interferon-induced protein 44 | 1.049e-4 | -3.262e+0 |
| pabpc4l | poly(A) binding protein, cytoplasmic 4-like | 5.139e-6 | -3.284e+0 |
| fam176b | family with sequence similarity 176, member B | 9.504e-7 | -3.340e+0 |
| cyp2r1 | cytochrome P450, family 2, subfamily r, polypeptide 1 | 2.252e-4 | -3.345e+0 |
| il15 | interleukin 15 | 3.086e-6 | -3.360e+0 |
| postn | periostin, osteoblast specific factor | 8.875e-6 | -3.367e+0 |
| mageh1 | melanoma antigen, family H, 1 | 3.120e-5 | -3.373e+0 |
| casp4 | caspase 4, apoptosis-related cysteine peptidase | 1.157e-6 | -3.380e+0 |
| hist2h2be | histone cluster 2, H2be | 3.546e-7 | -3.383e+0 |
| 5830431a10rik | RIKEN cDNA 5830431A10 gene | 6.000e-6 | -3.385e+0 |
| 2010001m09rik | RIKEN cDNA 2010001M09 gene | 9.699e-6 | -3.388e+0 |
| cytip | cytohesin 1 interacting protein | 6.072e-7 | -3.394e+0 |
| antxr2 | anthrax toxin receptor 2 | 1.298e-6 | -3.394e+0 |
| vegfc | vascular endothelial growth factor C | 1.016e-9 | -3.403e+0 |
| 1110067d22rik | RIKEN cDNA 1110067D22 gene | 5.443e-5 | -3.406e+0 |
| aw112010 | expressed sequence AW112010 | 2.234e-6 | -3.416e+0 |
| id3 | inhibitor of DNA binding 3 | 1.513e-5 | -3.449e+0 |
| crip1 | cysteine-rich protein 1 (intestinal) | 8.330e-7 | -3.453e+0 |
| oasl2 | 2'-5' oligoadenylate synthetase-like 2 | 5.277e-6 | -3.475e+0 |
| slc16a7 | solute carrier family 16 (monocarboxylic acid transporters), member 7 | 3.526e-5 | -3.541e+0 |
| c1qdc2 | C1q domain containing 2 | 1.367e-8 | -3.563e+0 |
| xlr3a | X-linked lymphocyte-regulated 3A | 1.160e-6 | -3.564e+0 |
| a230106d06rik | RIKEN cDNA A230106D06 gene | 1.734e-6 | -3.595e+0 |
| mn1 | meningioma 1 | 7.268e-7 | -3.599e+0 |
| hlf | hepatic leukemia factor | 8.886e-8 | -3.605e+0 |
| ai662270 | expressed sequence AI662270 | 4.116e-5 | -3.629e+0 |
| pdgfc | platelet-derived growth factor, C polypeptide | 6.569e-6 | -3.634e+0 |
| bank1 | B-cell scaffold protein with ankyrin repeats 1 | 5.509e-6 | -3.663e+0 |
| 1110006o17rik | RIKEN cDNA 1110006O17 gene | 4.006e-7 | -3.689e+0 |
| ampd3 | adenosine monophosphate deaminase 3 | 1.575e-5 | -3.705e+0 |
| slc28a2 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | 2.985e-5 | -3.729e+0 |
| klhl4 | kelch-like 4 (Drosophila) | 1.019e-6 | -3.784e+0 |
| gem | GTP binding protein (gene overexpressed in skeletal muscle) | 1.566e-5 | -3.819e+0 |
| loc215866 | hypothetical protein LOC215866 | 2.042e-7 | -3.822e+0 |
| tgfbi | transforming growth factor, beta induced | 1.854e-5 | -3.837e+0 |
| tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | 2.781e-7 | -3.845e+0 |
| esam | endothelial cell-specific adhesion molecule | 1.115e-6 | -3.849e+0 |
| gimap6 | GTPase, IMAP family member 6 | 6.739e-7 | -3.852e+0 |
| ottmusg00000016644 | predicted gene, OTTMUSG00000016644 | 2.731e-6 | -3.856e+0 |
| kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 5.393e-9 | -3.857e+0 |
| gimap4 | GTPase, IMAP family member 4 | 2.618e-7 | -3.865e+0 |
| gprc5b | G protein-coupled receptor, family C, group 5, member B | 2.009e-5 | -3.870e+0 |
| irf6 | interferon regulatory factor 6 | 7.680e-7 | -3.926e+0 |
| rnase6 | ribonuclease, RNase A family, 6 | 1.959e-5 | -3.944e+0 |
| tek | endothelial-specific receptor tyrosine kinase | 2.511e-5 | -3.980e+0 |
| rbpms | RNA binding protein gene with multiple splicing | 3.028e-9 | -3.990e+0 |
| plac8 | placenta-specific 8 | 4.268e-4 | -3.997e+0 |
| wdr40b | WD repeat domain 40B | 3.712e-8 | -4.057e+0 |
| robo4 | roundabout homolog 4 (Drosophila) | 3.117e-8 | -4.075e+0 |
| cpxm1 | carboxypeptidase X 1 (M14 family) | 1.561e-5 | -4.128e+0 |
| fmnl2 | formin-like 2 | 3.391e-7 | -4.138e+0 |
| bex1 | brain expressed gene 1 | 4.868e-8 | -4.168e+0 |
| gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) | 6.624e-7 | -4.194e+0 |
| bc022623 | cDNA sequence BC022623 | 1.165e-7 | -4.229e+0 |
| fgd5 | FYVE, RhoGEF and PH domain containing 5 | 2.127e-8 | -4.232e+0 |
| ctsh | cathepsin H | 2.172e-7 | -4.250e+0 |
| 1110017f19rik | RIKEN cDNA 1110017F19 gene | 1.123e-7 | -4.263e+0 |
| hmgn3 | high mobility group nucleosomal binding domain 3 | 8.184e-6 | -4.267e+0 |
| ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 9.708e-9 | -4.285e+0 |
| c330011k17rik | RIKEN cDNA C330011K17 gene | 5.638e-7 | -4.294e+0 |
| tjp1 | tight junction protein 1 | 1.628e-7 | -4.317e+0 |
| prtn3 | proteinase 3 | 1.528e-9 | -4.338e+0 |
| a630077b13rik | RIKEN cDNA A630077B13 gene | 1.594e-6 | -4.358e+0 |
| sox18 | SRY-box containing gene 18 | 1.432e-6 | -4.384e+0 |
| bc015286 | cDNA sequence BC015286 | 2.737e-6 | -4.417e+0 |
| igf2bp2 | insulin-like growth factor 2 mRNA binding protein 2 | 4.173e-6 | -4.430e+0 |
| mansc1 | MANSC domain containing 1 | 4.893e-6 | -4.441e+0 |
| evi1 | ecotropic viral integration site 1 | 2.742e-8 | -4.540e+0 |
| 6330403k07rik | RIKEN cDNA 6330403K07 gene | 3.322e-8 | -4.551e+0 |
| ltb | lymphotoxin B | 7.002e-6 | -4.635e+0 |
| 9530006c21rik | RIKEN cDNA 9530006C21 gene | 3.449e-6 | -4.638e+0 |
| acot1 | acyl-CoA thioesterase 1 | 4.238e-6 | -4.653e+0 |
| ocln | occludin | 1.329e-7 | -4.654e+0 |
| col4a1 | collagen, type IV, alpha 1 | 3.526e-8 | -4.679e+0 |
| s100a16 | S100 calcium binding protein A16 | 1.123e-9 | -4.702e+0 |
| cd79b | CD79B antigen | 1.733e-8 | -4.711e+0 |
| pdzk1ip1 | PDZK1 interacting protein 1 | 2.617e-8 | -4.755e+0 |
| 1810015c04rik | RIKEN cDNA 1810015C04 gene | 5.856e-8 | -4.805e+0 |
| evi5 | ecotropic viral integration site 5 | 7.857e-8 | -4.816e+0 |
| cdkn1c | cyclin-dependent kinase inhibitor 1C (P57) | 4.937e-8 | -4.828e+0 |
| tcfec | transcription factor EC | 2.605e-7 | -4.865e+0 |
| hrasls3 | HRAS like suppressor 3 | 7.078e-8 | -4.896e+0 |
| cd34 | CD34 antigen | 8.040e-6 | -4.920e+0 |
| 9030619p08rik | RIKEN cDNA 9030619P08 gene | 4.990e-6 | -4.977e+0 |
| krt18 | keratin 18 | 1.317e-6 | -5.030e+0 |
| expi | extracellular proteinase inhibitor | 1.016e-8 | -5.057e+0 |
| wfdc2 | WAP four-disulfide core domain 2 | 6.419e-9 | -5.116e+0 |
| gimap8 | GTPase, IMAP family member 8 | 5.789e-6 | -5.368e+0 |
| hnmt | histamine N-methyltransferase | 8.747e-7 | -5.411e+0 |
| as3mt | arsenic (+3 oxidation state) methyltransferase | 5.026e-9 | -5.424e+0 |
| emcn | endomucin | 9.000e-8 | -5.425e+0 |
| loc73899 | hypothetical LOC73899 | 1.733e-8 | -5.431e+0 |
| fstl1 | follistatin-like 1 | 5.890e-9 | -5.490e+0 |
| lsp1 | lymphocyte specific 1 | 6.283e-10 | -5.526e+0 |
| 0610040b09rik | RIKEN cDNA 0610040B09 gene | 2.097e-6 | -5.566e+0 |
| hoxa9 | homeo box A9 | 4.390e-9 | -5.672e+0 |
| ms4a6b | membrane-spanning 4-domains, subfamily A, member 6B | 1.171e-7 | -5.797e+0 |
| cd27 | CD27 antigen | 1.635e-8 | -5.877e+0 |
| col4a2 | collagen, type IV, alpha 2 | 4.588e-8 | -6.024e+0 |
| eltd1 | EGF, latrophilin seven transmembrane domain containing 1 | 4.154e-8 | -6.030e+0 |
| apoe | apolipoprotein E | 2.684e-8 | -6.326e+0 |
| xist | inactive X specific transcripts | 1.794e-8 | -6.464e+0 |
| ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 1.288e-9 | -6.923e+0 |
| smpdl3a | sphingomyelin phosphodiesterase, acid-like 3A | 1.199e-7 | -7.810e+0 |
| ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 2.070e-7 | -7.889e+0 |
| h19 | H19 fetal liver mRNA | 6.926e-9 | -8.322e+0 |